# Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

> **NCT00001826** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 50 (—)

## Conditions studied

- HIV Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001826
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 50 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001826, "Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00001826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*